Overview A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383. Status: Completed Trial end date: 2021-05-26 Target enrollment: Participant gender: Summary A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-383. Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical